Susan D Broz

Title: Susan D Broz: Innovator in Hematopoietic Cell Therapy

Introduction

Susan D Broz is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biomedical research, particularly in the development of agonist antibodies that target the flk2/flt3 receptor. Her work has the potential to enhance treatments for patients undergoing chemotherapy, radiation therapy, or bone marrow transplantation.

Latest Patents

Susan D Broz holds a patent for "Agonist antibodies against the flk2/flt3 receptor and uses thereof." This patent describes antibodies that bind to the extracellular domain of the flk2/flt3 receptor, activating its intracellular kinase domain. These labeled antibodies serve as diagnostics for detecting the presence of the flk2/flt3 receptor in primitive hematopoietic cells. Furthermore, they can stimulate the proliferation and differentiation of these cells, aiding in the repopulation of mature blood cell lineages in mammals affected by various medical conditions.

Career Highlights

Throughout her career, Susan has focused on innovative solutions in hematology and immunology. Her research has led to advancements in understanding how agonist antibodies can be utilized to treat conditions resulting from a decrease in blood cells due to disease or hemorrhage.

Collaborations

Susan has collaborated with notable colleagues, including Brian Drake Bennett and William Albert Matthews, to further her research and development efforts in this critical area of medicine.

Conclusion

Susan D Broz is a trailblazer in the field of hematopoietic cell therapy, with her innovative patent paving the way for new diagnostic and therapeutic approaches. Her contributions are vital for improving patient outcomes in hematological treatments.